Philips Medical Systems Nederland B.V. recalled its IntelliSpace Cardiovascular Software 8.0.0.4 on August 8, 2025. The recall affects four units distributed nationwide, particularly in Georgia, North Carolina, and Texas. The software displays outdated information, posing a significant risk to patient safety.
Software issue that results in the display of outdated information.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Philips Medical Systems Nederland B.V. or your healthcare provider for instructions. Notification method: Letter
The recall involves IntelliSpace Cardiovascular Software version 8.0.0.4. A total of four units were distributed across the United States, specifically in Georgia, North Carolina, and Texas.
The software issue results in the display of outdated medical information. This could lead to incorrect diagnoses or treatment decisions by healthcare providers.
No specific incidents have been reported. However, the potential for serious harm due to outdated information constitutes a high hazard level.
Stop using the software immediately. Follow the recall instructions from Philips Medical Systems or your healthcare provider for further guidance.
For more information, contact Philips Medical Systems Nederland B.V. or visit https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2543-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.